Selective use of radioactive iodine therapy for papillary thyroid cancers with low or lower-intermediate recurrence risk
Context: Current guidelines recommend a selective use of radioiodine treatment (RAI) for papillary thyroid cancer (PTC).
Objective: To determine how policy changes affect the use of RAI and the short-term outcomes of patients.
Design: Retrospective analysis of longitudinal data.
Setting: Academic referral center.